web analytics
0.4 C
Munich
Saturday, December 3, 2022

The Exciting Rise of MARIMED Inc (OTCMKTS: MRMD)

MARIMED Inc (OTCMKTS: MRMD) has seen a spectacular rise over the past few years from under $0.20 to recent highs of $4.07 per share. In recent months MRMD has transformed into a volume leader and is currently among the most active stocks on the OTCBB.

MRMD operates in the booming MJ sector that continues to grow; Cannabis research firm ArcView is projecting growth in North American legal sales to around $22 billion by 2021 from $6.9 billion in 2016. With Canada set to legalize recreational cannabis on October 17, pot stocks have been on fire.

MARIMED Inc (OTCMKTS: MRMD) is a multi-state professional cannabis organization that develops, owns and manages cannabis facilities and branded products lines. MariMed’s team has developed state-of-the-art regulatory-compliant facilities in DE, IL, NV, MD, MA, and RI which are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations. In addition, MariMed is on the forefront of precision dosed branded products for the treatment of specific medical symptoms. MariMed currently distributes its branded products in select states and is expanding licensing and distribution to numerous additional markets encompassing thousands of dispensaries.

Along with operational oversight, the Company provides its clients with legal, accounting, human resources, business development, and other corporate and administrative services. The Company also provides professional consultative services in all aspects of cannabis licensing procurement. To date, the Company has secured, on behalf of its clients, 11 cannabis licenses across five states—two in Delaware, two in Illinois, one in Nevada, three in Maryland and three in Massachusetts. Accordingly, the Company has developed seed-to-sale cannabis facilities across of these five states in excess of 300,000 square feet.

In addition, the Company licenses precision-dosed, cannabis-infused products to treat specific medical conditions or to achieve a certain result. These products are licensed under the brand names Kalm Fusion™ and Nature’s Heritage™, both of which were developed by the Company, and Betty’s Eddies™, acquired in October 2017. The Company also has exclusive sublicensing rights in certain states to distribute vaporizer pens developed by Lucid Mood™, as well as the clinically-tested medicinal cannabis strains developed in Israel by Tikun Olam™.

MRMD is doing big numbers! earlier this month the Company reported Q2 2018 financial results, posting revenue of $2.9 million for the three months ended June 30, 2018, an 81% increase from the same period in 2017. MariMed continued on a solid trajectory of year over year revenue growth that it has achieved each quarter since 2016.

To Find out the inside Scoop on MRMD Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Marimed is the in the process of improving the look and feel of Kalm Fusion™ and Betty’s Eddies™ brands of precision dosed cannabis infused products, and are working on acquiring and strategically aligning with other quality brands to manufacture and distribute through their networks nationwide

Most recently MariMed secured the exclusive global licensing and distribution rights to a proprietary print technology that produces precision dosed, rapid delivery, dissolvable cannabis products at new levels of efficiency. MariMed also invested in and will be distributing “Sprout,” a CRM platform and SMS messaging engine for customer acquisition and retention to dispensaries in multiple states.

Earlier this year MRMD acquired iRollie LLC, including its intellectual property (IP), clients, and its host of products and services. MariMed hired iRollie’s cofounders Luke Shepter and Joe Khoury to expand the iRollie business as well as to bring their expertise and services in house to support MariMed brands and clients. MariMed acquired iRollie and its executives in exchange for $600,000 in MariMed stock.

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $525 million market valuation MRMD has $5 million in the treasury, $45 million in assets, manageable debt and fast growing revenues reporting $2.9 million in sales for the three months ended June 30, 2018, an 81% increase from the same period in 2017. MRMD is becoming an early leader in the booming pot business and there is huge demand for the stock with MRMD regularly topping $500k in daily dollar volume. We will be updating on MRMD when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with MRMD.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in MRMD either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.